Characterization of reproductive hormonal dynamics in the perimenopause.

Medical therapy for women in the perimenopausal period is controversial, in part due to varying degrees of ovarian hormone secretion characteristic of this time of life. To extend our understanding of the reproductive endocrine milieu of perimenopausal women, we studied 6 cycling women, aged 47 yr and older, for 6 months with daily collections of first morning voided urine. Five additional older reproductive aged (43-47 yr old) women were studied with daily urine and serum sampling for a single menstrual cycle; their urinary hormone data were combined with the former group for menstrual cycle comparisons. Urine was assayed for LH, FSH, estrone conjugates, and pregnanediol glucuronide and normalized for creatinine (Cr). Eleven midreproductive aged (19-38 yr old) normally cycling women, 5 women with well defined premature ovarian failure, and 5 women aged 54 yr and older who were at least 1 yr postmenopausal were used for comparison. Perimenopausal women had shorter follicular phases (11 +/- 2 days vs. 14 +/- 1 days; P = 0.031) and, hence, shorter menstrual cycles than midreproductive aged controls. FSH excretion in perimenopausal women was greater than that in younger women (range of means, 4-32 vs 3-7 IU/g Cr; P = 0.0005). LH secretion was overall greater than that in younger normal subjects (range of means, 1.4-6.8 vs. 1.1-4.2 IU/g Cr; P < 0.026). Overall mean estrone conjugate excretion was greater in the perimenopausal women compared to that in the younger women [76.9 ng/mg Cr (range, 13.1-135) vs. 40.7 ng/mg Cr (range, 22.8-60.3); P = 0.023] and was similarly elevated in both follicular and luteal phases. Luteal phase pregnanediol excretion was diminished in the perimenopausal women compared to that in younger normal subjects (range for integrated pregnanediol, 1.0-8.4 vs. 1.6-12.7 microg/mg Cr/luteal phase; P = 0.015). Compared to postmenopausal women, perimenopausal women had more overall estrone excretion (2.5-6.2 ng/mg Cr in postmenopausal women; P = 0.02) and lower mean FSH (range of means for postmenopause, 24-85 IU/g Cr; P = 0.017) and LH (range for postmenopause, 4.3-14.8 IU/g Cr; P = 0.041). Compared to women with premature menopause, perimenopausal women again had lower FSH (range of means for premature menopause, 36-82 IU/g Cr; P = 0.0022), lower LH (range of means for premature menopause, 5.5-23.8 IU/g Cr; P = 0.0092), borderline higher mean estrone conjugates (range of means for premature menopause, 4-44 ng/mg Cr; P = 0.064), and far longer periods of ovarian activity (one to two cycles in prematurely menopausal women vs. three to six cycles in perimenopausal women). We conclude that altered ovarian function in the perimenopause can be observed as early as age 43 yr and include hyperestrogenism, hypergonadotropism, and decreased luteal phase progesterone excretion. These hormonal alterations may well be responsible for the increased gynecological morbidity that characterizes this period of life.

[1]  B. Eskenazi,et al.  Laboratory methods for evaluating early pregnancy loss in an industry-based population. , 2010, American journal of industrial medicine.

[2]  K. Matthews,et al.  Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. , 1994, Archives of internal medicine.

[3]  N. Santoro,et al.  Time-resolved immunofluorometric assay and specimen storage conditions for measuring urinary gonadotropins. , 1994, Clinical chemistry.

[4]  H. Burger,et al.  Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles. , 1991, The Journal of clinical endocrinology and metabolism.

[5]  K. Benirschke,et al.  Ovarian-pituitary hormone interactions during the perimenopause. , 1989, Maturitas.

[6]  S L Hui,et al.  Sex steroids and bone mass. A study of changes about the time of menopause. , 1987, The Journal of clinical investigation.

[7]  R. Gray,et al.  Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays. , 1987, The Journal of clinical endocrinology and metabolism.

[8]  C C Johnston,et al.  Steroid and gonadotropin levels in women during the peri-menopausal years. , 1986, Maturitas.

[9]  I. Macgillivray.  Epidemiology of twin pregnancy. , 1986, Seminars in perinatology.

[10]  M. Metcalf,et al.  Gonadotrophin excretion in fertile women: effect of age and the onset of the menopausal transition. , 1985, The Journal of endocrinology.

[11]  E. Lenton,et al.  Normal variation in the length of the follicular phase of the menstrual cycle: effect of chronological age , 1984, British journal of obstetrics and gynaecology.

[12]  H. Ory,et al.  Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. The Collaborative Review of Sterilization. , 1982, American journal of obstetrics and gynecology.

[13]  M. Metcalf,et al.  PITUITARY‐OVARIAN FUNCTION BEFORE, DURING AND AFTER THE MENOPAUSE: A LONGITUDINAL STUDY , 1982, Clinical endocrinology.

[14]  M. Metcalf,et al.  Classification of menstrual cycles in pre- and perimenopausal women. , 1981, The Journal of endocrinology.

[15]  M. Metcalf,et al.  PITUITARY‐OVARIAN FUNCTION IN NORMAL WOMEN DURING THE MENOPAUSAL TRANSITION , 1981, Clinical endocrinology.

[16]  S. Korenman,et al.  The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. , 1976, The Journal of clinical endocrinology and metabolism.

[17]  I. Fraser,et al.  Blood production and ovarian secretion rates of estradiol-17 beta and estrone in women with dysfunctional uterine bleeding. , 1974, The Journal of clinical endocrinology and metabolism.

[18]  James B. Brown,et al.  PRELIMINARY OBSERVATIONS ON URINARY OESTROGEN EXCRETION IN CERTAIN GYNAECOLOGICAL DISORDERS , 1959, The Journal of obstetrics and gynaecology of the British Empire.

[19]  Taussky Hh.  A microcolorimetric determination of creatine in urine by the Jaffe reaction. , 1954 .